The role of intrinsic fibrinolytic system activation in pathogenesis of hemostasis disturbances in hemodialyzed patients with chronic renal failure

Renal Failure

Volumn 26, Issue 3, 2004, Pages 223-229

  Bronisz, Marek ^a   Rość, Danuta ^b   Bronisz, Agata ^b   Manitius, Jacek ^b   Nartowicz, Edmund ^b  

^a Regional Hospital   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Dialysis; Intrinsic fibrinolytic system

Indexed keywords

ACETYLSALICYLIC ACID; AMINOTRANSFERASE; ANTIPLASMIN; COMPLEMENT COMPONENT C1S INHIBITOR; ENOXAPARIN; FIBRIN; FIBRINOGEN DEGRADATION PRODUCT; HEPARIN; PLASMIN; PREKALLIKREIN; TICLOPIDINE; UROKINASE;

ADULT; AGED; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUGLOBULIN LYSIS TEST; FEMALE; FIBRINOLYSIS; HEMODIALYSIS; HEMOSTASIS; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ADULT; AGED; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYSIS; GLOMERULONEPHRITIS; HEMOSTASIS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 3943075803     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120039519     Document Type: Article

References (35)

1. Lazarus, J.M.; Lowrie, E.G.; Hampers, C.L.; Merrill, J.P. Cardiovascular disease in uremic patients on hemodialysis. R.I. Med J, 1976, 59, 57-64, 72-74.
2. Ritz, E.; Wiecek, A.; Rambausek, M. Cardiovascular death in patients with end-stage renal failure: strategies for prevention. Nephrol. Dial. Transplant. 1994, 9 (Supp.), 120-128.
3. Chazan, J.A.; London, M.R.; Pono, L.M. Long-term survival of vascular accesses in a large chronic hemodialysis population. Nephron 1995, 69, 228-233.
4. Deykin, D. Uremic bleeding. Kidney Int. 1983, 24, 698-705.
5. Horowitz, H.I. Uremic toxins and platelet function. Arch. Intern. Med. 1970, 726, 823-826.
6. Di Paolo, N.; Capotondo, L.; Rossi, P.; Gaggiotti, E.; Pula, G.; Fanetti, G. Bleeding tendency of chronic uremia improved by vascular factor. Nephron 1989, 52, 268-272.
7. Remuzzi, G.; Livio, M.; Marchiaro, G.; Mecca, G.; de Gaetano, G. Bleeding in renal failure. Altered platelet function in chronic uraemia only partially corrected by hemodialysis. Nephron 1978, 22, 347-353.
8. Woolley, A.C. Platelet dysfunction in uremia. Kidney Int. 1987, 19, 15-20.
9. Skotnicki, A.B.; Sacha, T. Hemostasis Disturbances, 1st Ed.; Wydawnictwo Medycyna Praktyczna: Kraków, 1997.
10. Canaveses, C.; Stratta, P.; Pacitti, A.; Mangiarotti G.; Racca, M.; Ongelio, R.; Vercellone, A. Impaired fibrinolysis in uremia: partial and variable correction by four different dialysis regimens. Clin. Nephrol. 1982, 17, 82-89.
11. Winter, M.; Needham, J.; Mackie, I.; Cameron, J.S. Impaired vessel wall response to venous occlusion in patients with chronic renal failure on maintenance hemodialysis. Clin. Nephrol. 1984, 22, 307-313.
12. Pia̧tkowska, M.; Kotschy, M.; Nartowicz, E.; Rajewski, W. Tkankowy aktywator plazminogenu t-PA Ag i inhibitor aktywatora plazminogenu PAI-1 w czasie hemodializy u chorych na przewlekła̧ niewydolnoś ć nerek. Pol. Merkuriusz Lek. 1997, 2, 205-207.
13. Małyszko, J.; Małyszko, J.S.; Myśliwiec, M. Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis. Perit. Dial. Int. 2001, 21, 158-165.
14. Speiser, W.; Wojta, J.; Korninger, Ch.; Kirchheimer, J.C.; Zazgornik, J.; Binder, B. Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis. Kidney Int. 1987, 32, 280-283.
15. Erdem, Y.; Haznedaroglu, I.C.; Celik, I.; Yalcin A.U.; Yasavul, U.; Turgan C.; Caglar, S. Coagulation, fibrinolysis and fibrinolysis inhibitors in hemodialysis patients: contribution of arteriovenous fistula. Nephrol. Dial. Transplant. 1996, 11, 1299-1305.
16. Malyszko, J.; Małyszko, J.S.; Pawlak, D.; Pawlak, K.; Buczko, W.; Myśliwiec, M. Hemostasis, platelet function and serotonin in acute and chronic renal failure. Thromb. Res. 1996, 83, 351-361.
17. Matsuo, T.; Koide, M.; Kario, K.; Suzuki, S.; Matsuo, M. Extrinsic coagulation factors and tissue factor pathway inhibitor in end-stage chronic renal failure. Hemostasis 1997, 27, 163-167.
18. Wardle, E.N.; Piercy, D.A. Studies of contact activation of blood in hemodialysis. J. Clin. Pathol. 1972, 25, 1045-1049.
19. Brown, N.J.; Nadeau, J.H.; Vaughan, D.E. Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin. Thromb. Haemost. 1997, 77, 522-525.
20. Loza, J.P.; Gurewich, V.; Johnstone, M.; Pannell, R. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis. Thromb. Haemost. 1994, 71, 347-352.
21. Motta, G.; Rojkjaer, R.; Hasan, A.K.; Cines, D.B.; Schmaier, A.H. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. Blood 1998, 91, 516-528.
22. Boisclar, M.D.; Philippou, H.; Lane, D.A. Thrombogenic mechanisms in the human: fresh insights obtained by immunodiagnostic studies of coagulation markers. Blood Coagul. Fibrinolysis. 1993, 4, 1007-1021.
23. Vaziri, N.D.; Toohey, J.; Paule, P.; Alikhani, S.; Hung, E. Effect of hemodialysis on contact group of coagulation factors, platelets and leukocytes. Am. J. Med. 1984, 77, 441-473.
24. Nakamura, Y.; Tomura, S.; Tachibana, K.; Chida, Y.; Marumo, F. Enhanced fibrinolytic activity during the course of hemodialysis. Clin. Nephrol. 1992, 38, 90-96.
25. Takagi, M.; Wada, H.; Mukai, K.; Kihira, H.; Yano, S.; Minamikawa, K.; Wakita, Y.; Nakase, T.; Nagaya. S.; Deguchi, K.; Shirakawa, S.; Suzuki, K. Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance hemodialysis. Blood Coagul. Fibrinolysis. 1994, 5, 713-717.
26. Inoue, A.; Wada, H.; Takagi, M.; Yamamuro, M.; Mukai, K.; Nakasaki, T.; Shimura, M.; Hiyoyama, K.; Deguchi, H.; Gabazza, E.C.; Mori, Y.; Nishikawa, M.; Deguchi, K.; Shiku, H. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis. Clin. Appl. Thromb. Hemost. 2000, 6, 100-103.
27. Lane, D.A.; Ireland, H.; Knight, I.; Wolff, S.; Kyle, P.; Curtis, J.R. The significance of fibrinogen derivatives in plasma in human renal failure. Brit. J. Haematol. 1984, 56, 251-260.
28. Tomura, S.; Oono, Y.; Kuriyama, R.; Takeuchi, J. Plasma concentrations of fibrinopeptide A and fibrinopeptide Bβ15-42 in glomerulonephritis and the nephrotic syndrome. Arch. Intern. Med. 1985, 145, 1033-1035.
29. Groth, T.; Synowitz, J.; Malsch, G.; Richau, K.; Albrecht, W.; Lange, K.-P.; Paul, D. Contact activation of plasmatic coagulation on polymeric membranes by the activity of kallikrein in heparinized plasma. J. Biomater. Sci., Polym. Edn. 1997, 8, 797-807.
30. Matata, B.M.; Courtney, J.M.; Sundaram, S.; Wark, S.; Bowry, S.K.; Vienken, J.; Lowe, G.D.O. Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes. J. Biomed. Mater. Res. 1996, 31, 63-70.
31. Rość, D.; Bronisz, M.; Zastawna, E.; Manitius, J. Układ fibrynolizy we krwi chorych na przewlekła̧ niewydolność nerek poddawanych hemodializie. Nefrol. Dializoterapia Pol. 2000, 4, 156-160.
32. Margolius, H.S. Kallikreins and kinins. Molecular characteristics and cellular and tissue responses. Diabetes 1996, 45 (Supp.), 14-19.
33. Ishii, Y.; Yano, S.; Kanai, H.; Maezawa, A.; Tsuchida, A.; Wakamatsu, R.; Naruse, T. Evaluation of blood coagulation-fibrinolysis system in patients receiving chronic hemodialysis. Nephron 1996, 73, 407-412.
34. Nakamura, Y.; Chida, Y.; Tomura, S. Enhanced coagulation-fibrinolysis in patients on regular hemodialysis treatment. Nephron 1991, 58, 201-204.
35. Tomura, S.; Nakamura, Y.; Deguchi, F.; Ando, R.; Chida, Y.; Marumo, F. Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment. Thromb. Res. 1991, 64, 81-90.